ABL Bio “Continues clinical trials of anticancer drug candidates and collaboration with global big pharma”

(Seoul = Yonhap News) Reporter Shin Seon-mi = Lee Sang-hoon, CEO of ABL Bio [298380], said on the 7th, "We are doing our best to increase corporate value by expanding technology transfer and advancing clinical trials and data...